Interestingly, the level of total ACC, predominantly ACC1, was a critical factor in the reprogramming of cancer metabolism in HNSCC cells with acquired cetuximab resistance, shifting the dependence from glycolysis to lipogenesis. The gene discussed is ACACA; the disease is head and neck squamous cell carcinoma.